Show
Sort by
-
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP
-
- Journal Article
- A1
- open access
Consensus criteria for chronic rhinosinusitis disease control : an international Delphi Study
-
EPOS/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023
-
- Journal Article
- A1
- open access
The EUFOREA pocket guide for chronic rhinosinusitis
-
- Journal Article
- A1
- open access
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP
-
European position paper on rhinosinusitis and nasal polyps 2020
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP
-
Rhinology Future Debates 2018, a EUFOREA report
-
- Journal Article
- A1
- open access
Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak : ERS endorsed services
-
- Journal Article
- A1
- open access
The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort : a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps